Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Positive and Placebo-Controlled Trial to Evaluate the Effects of Milademetan Administration on Cardiac Repolarization in Healthy Subjects

NCT05758818 is registered in ClinicalTrials.gov with Rain Oncology Inc as lead sponsor.

NCT NCT05758818
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05758818 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Positive and Placebo-Controlled Trial to Evaluate the Effects of Milademetan Administration on Cardiac Repolarization in Healthy Subjects
Lead sponsor
Rain Oncology Inc
Phase
Phase 1
Overall status
Terminated
Start date
April 17, 2023
Completion date
June 8, 2023
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac repolarization